RiverVest Funds I, II & III RiverVest Fund IV Archer Seed Fund

25 Jul

Posted at 20:21h in RiverVest News by

July 2023RiverVest's Niall O'Donnell Discusses State of Biotech VC in 2023 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} RiverVest Managing Director Niall O'Donnell, Ph.D.ST. LOUIS, MO (July 21, 2023) – From the St. Louis Business Journal, Beyond the List: St. Louis area's largest...

10 Mar

Posted at 20:57h in RiverVest News by

March 2023RiverVest Mourns Passing of William A. Peck, MD,RiverVest Scientific Advisory Board Founding Member /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} William A. Peck, MDSeptember 28, 1933 - February 22, 2023In MemoriamWe mourn the passing of William A. Peck, MD, who as the...

07 Sep

Posted at 00:00h in RiverVest News by

SEPT 2022Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 7, 2022)Read the Press ReleaseGood Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive...

22 Aug

Posted at 00:00h in RiverVest News by

AUG 2022Teleflex to Acquire Portfolio Company Standard Bariatrics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 22, 2022)Read the Press ReleaseST. LOUIS (August 22, 2022) – Standard Bariatrics – a RiverVest Venture Fund IV portfolio company – has entered into a...

28 Apr

Posted at 00:00h in RiverVest News by

AUG 2021Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 26, 2021)Read the Press ReleaseNEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...

24 Mar

Posted at 00:00h in RiverVest News by

MAR 2021What's next for RiverVest Venture Partners after raising its largest-ever investment fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 24, 2021)Read the Press ReleaseST. LOUIS, MO (Mar. 24, 2021) – From the St. Louis Business JournalRiverVest Venture Partners has...

23 Mar

Posted at 00:00h in RiverVest News by

MAR 2021RiverVest Venture Partners Closes $275 Million Life Sciences Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 23, 2021)Oversubscribed fund to continue investing in high-impact biopharma and medical device innovationST. LOUIS (March 23, 2021) – RiverVest Venture Partners, a leading...

16 Feb

Posted at 00:00h in RiverVest News by

FEB 2021Pascal Krotee Joins RiverVest as Senior Associate /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (February 16, 2021)St. Louis, MO (Feb 16, 2021) – Life science venture capital firm RiverVest continues to expand its team with the addition of Pascal Krotee...

01 Sep

Posted at 00:00h in RiverVest News by

SEPT 2020RiverVest Expands Analyst and Marketing & Communications Teams /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 1, 2020)ST. LOUIS, MO (September 1, 2020) – Life science venture capital firm RiverVest has expanded its team with additions to the analyst and...

03 Jan

Posted at 00:00h in RiverVest News by

JAN 2020RiverVest's Tom Melzer Forecasts St. Louis VC, Start-up Growth for 2020 /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 3, 2020) St. Louis Business JournalRead the Press ReleasePerhaps no part of the St. Louis economy surged in the past decade more...

23 Jul

Posted at 00:00h in RiverVest News by

JULY 2019Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (July 23, 2019)ST. LOUIS, MO (July 23, 2019) – Life sciences venture capital firm RiverVest Venture Partners today announced the continued...

24 May

Posted at 00:00h in RiverVest News by

MAY 2019RiverVest Mourns Passing of Co-Founder Andrew B. Craig III /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (May 24, 2019)We mourn the passing of our co-founder, partner and friend, Andrew B. Craig III. He was essential to RiverVest’s founding in 2000...

20 May

Posted at 00:00h in RiverVest News by

MAY 2019RiverVest Builds Another San Diego Based Biopharma Company /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (May 20, 2019)Read the Press ReleaseRiverVest Managing Director Niall O’Donnell is the CEO of Reneo Pharmacueticals, which recently announced a $50M series A financing in which RiverVest...

22 Jan

Posted at 00:00h in RiverVest News by

JAN 2019Sivan Weitzman Joins RiverVest Venture Partners as CFO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 22, 2019)ST. LOUIS, MO (Jan. 22, 2019) – Life sciences venture capital firm RiverVest Venture Partners today announced that Sivan Weitzman has joined the firm as...

18 Dec

Posted at 00:00h in RiverVest News by

DEC 2018RiverVest Venture Partners Closes on Oversubscribed $184.4 Million Life Science Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (December 18, 2018)ST. LOUIS, MO (Dec. 18, 2018) – Life sciences venture capital firm RiverVest Venture Partners today announced the final closing...

18 Mar

Posted at 00:00h in RiverVest News by

APR 2018RiverVest Venture Partners' Portfolio Company Securus Sold to Boston Scientific Represents 9th Exit from RiverVest Venture Fund II /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS and CLEVELAND (April 3, 2018)ST. LOUIS and CLEVELAND (April 3, 2018) – RiverVest Venture Partners...